Learning from the cerivastatin experience

Lancet. 2001 Oct 27;358(9291):1383-5. doi: 10.1016/S0140-6736(01)06489-3.
No abstract available

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Mice
  • Myositis / chemically induced*
  • Pyridines / adverse effects*
  • Pyridines / metabolism
  • Rhabdomyolysis / chemically induced*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyridines
  • cerivastatin